Floatz logo

Therapeutic Asset Ratings

3,272 results matching 1 filter

91,564 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Trastuzumab
Gastric Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Trastuzumab
Head And Neck Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Trastuzumab
Hematopoietic And Lymphoid Cell Neoplasm
National Cancer Institute (NCI)P2CCC (53)
Trastuzumab
Renal Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Trastuzumab
Lung Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Trastuzumab
Uterine Corpus Cancer
National Cancer Institute (NCI)P2CCC (53)
Trastuzumab
Uterine Cancer
National Cancer Institute (NCI)P2CCC (53)
Trastuzumab
Skin Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Trastuzumab
Thyroid Gland Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Trastuzumab Emtansine
Cervical Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Trastuzumab Emtansine
Colon Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Trastuzumab Emtansine
Endometrial Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Trastuzumab Emtansine
Carcinoma Of Esophagus
National Cancer Institute (NCI)P2CCC (53)
Trastuzumab Emtansine
Gastric Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Trastuzumab Emtansine
Head And Neck Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Trastuzumab Emtansine
Hematopoietic And Lymphoid Cell Neoplasm
National Cancer Institute (NCI)P2CCC (53)
Trastuzumab Emtansine
Renal Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Trastuzumab Emtansine
Hepatocellular Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Trastuzumab Emtansine
Lung Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Trastuzumab Emtansine
Uterine Corpus Cancer
National Cancer Institute (NCI)P2CCC (53)
Trastuzumab Emtansine
Uterine Cancer
National Cancer Institute (NCI)P2CCC (53)
Trastuzumab Emtansine
Rectal Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Trastuzumab Emtansine
Skin Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Trastuzumab Emtansine
Thyroid Gland Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Tuvusertib
Prostate Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Showing 2101 to 2125 of 3,272 assets
PreviousPage 85 of 131Next